A 1-minute blood test detects decreased immune function and increased clinical risk in COVID-19 patients
Chirajyoti Deb
(Translational Research and Specialty Diagnostic Laboratory, Arnold Palmer Hospital for Children, Orlando Health)
Allan N. Salinas
(Translational Research and Specialty Diagnostic Laboratory, Arnold Palmer Hospital for Children, Orlando Health)
Tianyu Zheng
(Nano Discovery Inc.)
Aurea Middleton
(Center for Nursing Research, Orlando Health)
Katelyn Kern
(Center for Digestive Health and Nutrition, Arnold Palmer Hospital for Children, Orlando Health)
Daleen Penoyer
(Center for Nursing Research, Orlando Health)
Rahul Borsadia
(Internal Medicine Group, Orlando Health)
Charles Hunley
(Critical Care Medicine, Orlando Health)
Bassam Abomoelak
(Translational Research and Specialty Diagnostic Laboratory, Arnold Palmer Hospital for Children, Orlando Health)
Vijay Mehta
(Center for Digestive Health and Nutrition, Arnold Palmer Hospital for Children, Orlando Health)
Laura Irastorza
(Center for Digestive Health and Nutrition, Arnold Palmer Hospital for Children, Orlando Health)
Devendra I. Mehta
(Translational Research and Specialty Diagnostic Laboratory, Arnold Palmer Hospital for Children, Orlando Health)
Qun Huo
(Department of Chemistry and NanoScience Technology Center, University of Central Florida)
Abstract Upon infection with SARS-CoV-2, the virus that causes COVID-19, most people will develop no or mild symptoms. However, a small percentage of the population will become severely ill, and some will succumb to death. The clinical severity of COVID-19 has a close connection to the dysregulation of the patient’s immune functions. We previously developed a simple, nanoparticle-enabled blood test that can determine the humoral immune status in animals. In this study, we applied this new test to analyze the immune function in relation to disease severity in COVID-19 patients. From the testing of 153 COVID-19 patient samples and 142 negative controls, we detected a drastic decrease of humoral immunity in COVID-19 patients who developed moderate to severe symptoms, but not in patients with no or mild symptoms. The new test may be potentially used to monitor the immunity change and predict the clinical risk of patients with COVID-19.
Chirajyoti Deb, Allan N. Salinas, Tianyu Zheng, et al. (2021). "A 1-minute blood test detects decreased immune function and increased clinical risk in COVID-19 patients". Scientific Reports. https://doi.org/10.1038/s41598-021-02863-2